Magsayo, Novie Jane J.

HRN: 28-13-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2025
MEBENDAZOLE 500MG (TAB)
11/21/2025
11/28/2025
PO
500mg
TID X 7 Days
Thickly MSAF; RMLE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines